FDA Clearance Tracker · P080020-S020
GEL-ONE(R)
Last checked: Nov 20, 2026Latest source record: Sep 27, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 27, 2016
Approved
Time to decision
179 days
Received Apr 1, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P080020-S020
- Device name
- GEL-ONE(R)
- Applicant
- Seikagaku Corp.
- Applicant location
- Tokyo
- Received
- Apr 1, 2016
- Decided
- Sep 27, 2016
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P080020
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for Gel-One. The device is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics, e.g., acetaminophen.
Source documents
Other decisions for Seikagaku Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VISCO-3PMA supplement
P980044-S027 · Decided Dec 21, 2015 · 166 days after receipt · Panel Track
Device type: Acid, hyaluronic, intraarticular (MOZ) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.